Litcius/Paper detail

Addition of immunotherapy to chemotherapy for metastatic triple-negative breast cancer: A systematic review and meta-analysis of randomized clinical trials

Xingfa Huo, Guoshuang Shen, Zhen Liu, Yuhua Liang, Jinming Li, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao

2021Critical Reviews in Oncology/Hematology19 citationsDOI

Topics & Concepts

MedicineInternal medicineOncologyChemotherapyHazard ratioBreast cancerPopulationTriple-negative breast cancerCochrane LibraryAdverse effectMeta-analysisClinical endpointCancerRandomized controlled trialConfidence intervalEnvironmental healthCancer Immunotherapy and BiomarkersAdvanced Breast Cancer TherapiesBreast Cancer Treatment Studies
Addition of immunotherapy to chemotherapy for metastatic triple-negative breast cancer: A systematic review and meta-analysis of randomized clinical trials | Litcius